vs
OOMA INC（OOMA）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
OOMA INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.9倍（$67.6M vs $35.5M），OOMA INC净利率更高（2.1% vs -304.2%，领先306.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 3.8%），OOMA INC自由现金流更多（$5.4M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 4.7%）
Ooma Inc是一家总部位于美国加利福尼亚州硅谷的上市电信企业，面向家庭、企业以及移动用户提供包含VoIP网络电话在内的各类通讯服务，在电信服务领域拥有成熟的业务布局。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
OOMA vs RXRX — 直观对比
营收规模更大
OOMA
是对方的1.9倍
$35.5M
营收增速更快
RXRX
高出677.9%
3.8%
净利率更高
OOMA
高出306.3%
-304.2%
自由现金流更多
OOMA
多$52.8M
$-47.3M
两年增速更快
RXRX
近两年复合增速
4.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $67.6M | $35.5M |
| 净利润 | $1.4M | $-108.1M |
| 毛利率 | 60.2% | 59.8% |
| 营业利润率 | 1.9% | -304.8% |
| 净利率 | 2.1% | -304.2% |
| 营收同比 | 3.8% | 681.7% |
| 净利润同比 | 158.9% | 39.6% |
| 每股收益（稀释后） | $0.05 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OOMARXRX
| Q4 25 | $67.6M | $35.5M | ||
| Q3 25 | $66.4M | $5.2M | ||
| Q2 25 | $65.0M | $19.2M | ||
| Q1 25 | $65.1M | $14.7M | ||
| Q4 24 | $65.1M | $4.5M | ||
| Q3 24 | $64.1M | $26.1M | ||
| Q2 24 | $62.5M | $14.4M | ||
| Q1 24 | $61.7M | $13.8M |
净利润OOMARXRX
| Q4 25 | $1.4M | $-108.1M | ||
| Q3 25 | $1.3M | $-162.3M | ||
| Q2 25 | $-141.0K | $-171.9M | ||
| Q1 25 | — | $-202.5M | ||
| Q4 24 | $-2.4M | $-178.9M | ||
| Q3 24 | $-2.1M | $-95.8M | ||
| Q2 24 | $-2.1M | $-97.5M | ||
| Q1 24 | — | $-91.4M |
毛利率OOMARXRX
| Q4 25 | 60.2% | 59.8% | ||
| Q3 25 | 60.6% | -183.8% | ||
| Q2 25 | 61.8% | -4.9% | ||
| Q1 25 | 61.3% | -48.0% | ||
| Q4 24 | 60.3% | -181.4% | ||
| Q3 24 | 60.3% | 53.7% | ||
| Q2 24 | 61.0% | 36.2% | ||
| Q1 24 | 61.2% | 19.1% |
营业利润率OOMARXRX
| Q4 25 | 1.9% | -304.8% | ||
| Q3 25 | 1.4% | -3327.6% | ||
| Q2 25 | -0.1% | -916.8% | ||
| Q1 25 | -0.5% | -1297.9% | ||
| Q4 24 | -3.5% | -4042.4% | ||
| Q3 24 | -2.5% | -377.1% | ||
| Q2 24 | -4.4% | -697.4% | ||
| Q1 24 | -3.9% | -698.4% |
净利率OOMARXRX
| Q4 25 | 2.1% | -304.2% | ||
| Q3 25 | 1.9% | -3135.3% | ||
| Q2 25 | -0.2% | -894.2% | ||
| Q1 25 | — | -1373.3% | ||
| Q4 24 | -3.6% | -3935.5% | ||
| Q3 24 | -3.3% | -367.5% | ||
| Q2 24 | -3.4% | -676.6% | ||
| Q1 24 | — | -662.4% |
每股收益（稀释后）OOMARXRX
| Q4 25 | $0.05 | $-0.17 | ||
| Q3 25 | $0.04 | $-0.36 | ||
| Q2 25 | $-0.01 | $-0.41 | ||
| Q1 25 | $-0.01 | $-0.50 | ||
| Q4 24 | $-0.09 | $-0.56 | ||
| Q3 24 | $-0.08 | $-0.34 | ||
| Q2 24 | $-0.08 | $-0.40 | ||
| Q1 24 | $-0.12 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $21.7M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $90.0M | $1.1B |
| 总资产 | $152.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资OOMARXRX
| Q4 25 | $21.7M | $743.3M | ||
| Q3 25 | $19.6M | $659.8M | ||
| Q2 25 | $19.0M | $525.1M | ||
| Q1 25 | $17.9M | $500.5M | ||
| Q4 24 | $17.1M | $594.4M | ||
| Q3 24 | $16.6M | $427.6M | ||
| Q2 24 | $15.6M | $474.3M | ||
| Q1 24 | $17.5M | $296.3M |
总债务OOMARXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | $0 | $16.4M | ||
| Q4 24 | $3.0M | $19.0M | ||
| Q3 24 | $8.5M | $20.5M | ||
| Q2 24 | $11.5M | $22.9M | ||
| Q1 24 | $16.0M | — |
股东权益OOMARXRX
| Q4 25 | $90.0M | $1.1B | ||
| Q3 25 | $88.1M | $1.0B | ||
| Q2 25 | $87.7M | $919.1M | ||
| Q1 25 | $85.3M | $933.9M | ||
| Q4 24 | $83.5M | $1.0B | ||
| Q3 24 | $81.8M | $524.6M | ||
| Q2 24 | $81.0M | $584.4M | ||
| Q1 24 | $78.1M | $401.2M |
总资产OOMARXRX
| Q4 25 | $152.7M | $1.5B | ||
| Q3 25 | $150.1M | $1.4B | ||
| Q2 25 | $148.8M | $1.3B | ||
| Q1 25 | $149.2M | $1.3B | ||
| Q4 24 | $149.6M | $1.4B | ||
| Q3 24 | $151.5M | $726.5M | ||
| Q2 24 | $155.2M | $775.9M | ||
| Q1 24 | $159.3M | $557.8M |
负债/权益比OOMARXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | 0.00× | 0.02× | ||
| Q4 24 | 0.04× | 0.02× | ||
| Q3 24 | 0.10× | 0.04× | ||
| Q2 24 | 0.14× | 0.04× | ||
| Q1 24 | 0.20× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.9M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $5.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | 8.1% | -133.1% |
| 资本支出强度资本支出/营收 | 2.2% | 3.5% |
| 现金转化率经营现金流/净利润 | 4.97× | — |
| 过去12个月自由现金流最近4个季度 | $19.1M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流OOMARXRX
| Q4 25 | $6.9M | $-46.1M | ||
| Q3 25 | $6.4M | $-117.4M | ||
| Q2 25 | $3.7M | $-76.4M | ||
| Q1 25 | $7.8M | $-132.0M | ||
| Q4 24 | $8.1M | $-115.4M | ||
| Q3 24 | $7.1M | $-59.2M | ||
| Q2 24 | $3.6M | $-82.2M | ||
| Q1 24 | $5.5M | $-102.3M |
自由现金流OOMARXRX
| Q4 25 | $5.4M | $-47.3M | ||
| Q3 25 | $5.0M | $-117.6M | ||
| Q2 25 | $2.5M | $-79.6M | ||
| Q1 25 | $6.1M | $-133.8M | ||
| Q4 24 | $6.5M | $-116.7M | ||
| Q3 24 | $5.3M | $-63.8M | ||
| Q2 24 | $2.1M | $-83.4M | ||
| Q1 24 | $4.2M | $-109.0M |
自由现金流率OOMARXRX
| Q4 25 | 8.1% | -133.1% | ||
| Q3 25 | 7.6% | -2272.5% | ||
| Q2 25 | 3.8% | -413.9% | ||
| Q1 25 | 9.4% | -907.4% | ||
| Q4 24 | 10.0% | -2567.7% | ||
| Q3 24 | 8.3% | -244.6% | ||
| Q2 24 | 3.4% | -578.5% | ||
| Q1 24 | 6.9% | -789.9% |
资本支出强度OOMARXRX
| Q4 25 | 2.2% | 3.5% | ||
| Q3 25 | 2.0% | 4.7% | ||
| Q2 25 | 1.9% | 16.4% | ||
| Q1 25 | 2.6% | 12.4% | ||
| Q4 24 | 2.4% | 28.6% | ||
| Q3 24 | 2.7% | 17.5% | ||
| Q2 24 | 2.3% | 8.2% | ||
| Q1 24 | 2.1% | 48.2% |
现金转化率OOMARXRX
| Q4 25 | 4.97× | — | ||
| Q3 25 | 5.07× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OOMA
| Subscription And Services Revenue | $62.0M | 92% |
| Product And Other Revenue | $5.7M | 8% |
RXRX
暂无分部数据
